Propyl Phosphate

Propyl Phosphate

SCHEMBL3067766

CCCOP(=O)([O-])[O-].C[P+](C)(C)C.C[P+](C)(C)C

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 2/20 0.37
LMNA P02545 3/20 0.33
ESR1 P03372 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CDC25A P30304 1/20 0.33
AGTR1 P30556 1/20 0.33
AKT1 P31749 1/20 0.33
ADRA1A P35348 1/20 0.33
KCNH2 Q12809 1/20 0.33
LPAR3 Q9UBY5 3/20 0.32
LPAR1 Q92633 2/20 0.32
LPAR2 Q9HBW0 2/20 0.32
TSHR P16473 2/20 0.32
LPAR5 Q9H1C0 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HMGCR P04035 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propyl Phosphate SCHEMBL11807155 0.92 CYP3A4 (0.42) MEN1KMT2ACYP3A4LMNAESR1
Propyl Phosphate SCHEMBL4077608 0.90
Propyl Phosphate SCHEMBL29043717 0.90 CYP3A4 (0.40) MEN1KMT2ACYP3A4LMNAESR1
Propyl Phosphate SCHEMBL7947918 0.90 CYP3A4 (0.40) MEN1KMT2ACYP3A4LMNAESR1
Propyl Phosphate SCHEMBL4350744 0.90 CYP3A4 (0.40) MEN1KMT2ACYP3A4LMNAESR1
Propyl Phosphate SCHEMBL4077358 0.90
Propyl Phosphate SCHEMBL4069767 0.90
Propyl Phosphate SCHEMBL11754788 0.90
Propyl Phosphate SCHEMBL3067608 0.86 MEN1 (0.35) MEN1KMT2ACYP3A4LMNAESR1
Propyl Phosphate SCHEMBL14856144 0.85 MEN1 (0.38) MEN1KMT2ACYP3A4LMNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2010-10-21 US disclosed
US-20090118442-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT ELL, RAD54L, RPP30 MEN1 4816/4885KMT2A 2040/4885CYP3A4 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.